...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Adenovirus-Mediated Delivery and Expression of a cAMP-Dependent Protein Kinase Inhibitor Gene to BEAS-2B Epithelial Cells Abolishes the Anti-Inflammatory Effects of Rolipram,Salbutamol,and Prostaglandin E_2:A Comparison with H-89
【24h】

Adenovirus-Mediated Delivery and Expression of a cAMP-Dependent Protein Kinase Inhibitor Gene to BEAS-2B Epithelial Cells Abolishes the Anti-Inflammatory Effects of Rolipram,Salbutamol,and Prostaglandin E_2:A Comparison with H-89

机译:腺病毒介导的cAMP依赖性蛋白激酶抑制剂基因向BEAS-2B上皮细胞的传递和表达消除了咯利普兰,沙丁胺醇和前列腺素E_2的抗炎作用:与H-89的比较

获取原文
获取原文并翻译 | 示例
           

摘要

cAMP-elevating drugs are thought to mediate their biological effects by activating the cAMP/cAMP-dependent protein kinase (PKA)cascade.However,this hypothesis is difficult to confirm due to a lack of selective inhibitors.Here,we have probed the role of PKA in mediating inhibitory effects of several cAMP-elevating drugs in BEAS-2B epithelial cells using an adenovirus vector encoding a PKA inhibitor protein (PKIalpha)and have compared it to H-89,a commonly used small molecule PKA inhibitor.Initial studies established efficient gene transfer and confirmed functionality of PKIalpha 48 h after virus infection.All cAMP-elevating drugs tested promoted the phosphorylation of cAMP response element-binding protein (CREB),activated a cAMP response element (CRE)-driven luciferase reporter gene,and suppressed both granulocyte/macrophage colony-stimulating factor (GM-CSF)generation and [~3H]arachidonic acid (AA)release in response to interleukin-1 betaand monocyte chemotactic protein (MCP)-1,respectively.These effects were abolished by PKIalpha.In contrast,H-89 behaved unpre-dictably under the same conditions.Thus,although CREB phosphorylation evoked by a range of cAMP-elevating drugs was abolished by H-89,neither activation of the CRE-dependent luciferase reporter gene construct nor the inhibition of GM-CSF generation was inhibited.Paradoxically,H-89 antagonized MCP-1-induced [~3H]AA release and enhanced the inhibitory effect of submaximal concentrations of rolipram and 8-bromo-cAMP.We suggest that expression of PKIlpha in susceptible cells provides a simple and unambiguous way to assess the role of PKA in cAMP signaling and to probe the mechanism of action of other drugs and cAMP-dependent responses where the participation of PKA is equivocal.Furthermore,these data suggest that H-89 is not a selective inhibitor of PKA and should be avoided.
机译:cAMP升高药物被认为可以通过激活cAMP / cAMP依赖性蛋白激酶(PKA)级联来介导其生物学作用。但是,由于缺乏选择性抑制剂,这一假设很难得到证实。在这里,我们探讨了cAMP的作用。 PKA通过使用编码PKA抑制剂蛋白(PKIalpha)的腺病毒载体介导BEAS-2B上皮细胞中几种cAMP升高药物的抑制作用,并将其与常用的小分子PKA抑制剂H-89进行了比较。病毒感染后48 h PKIalpha基因转移并证实其功能。所有测试的cAMP升高药物均能促进cAMP反应元件结合蛋白(CREB)的磷酸化,激活cAMP反应元件(CRE)驱动的荧光素酶报道基因,并抑制两者尊重白细胞介素-1β和单核细胞趋化蛋白(MCP)-1响应粒细胞/巨噬细胞集落刺激因子(GM-CSF)的产生和[〜3H]花生四烯酸(AA)的释放相反,H-89在相同条件下的表现却无法预测。因此,尽管一系列cAMP升高药物引起的CREB磷酸化被H-89消除,但CRE均未激活H-89拮抗MCP-1诱导的[〜3H] AA释放,并增强了最大浓度的咯利普兰和8-溴-cAMP的抑制作用,相反,H-89拮抗了MCP-1诱导的[〜3H] AA释放。我们建议,PKIlpha在易感细胞中的表达为评估PKA在cAMP信号传导中的作用以及探讨其他药物和cAMP依赖性反应的机制提供了一种简单明确的方法,其中PKA的参与是模棱两可的。这些数据表明,H-89不是PKA的选择性抑制剂,应避免使用。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号